Clinical relevance of comprehensive genomic analysis in patients with advanced-stage neuroendocrine neoplasms: Results from the MASTER trial of the German Cancer Consortium

Kreutzfeldt S, Apostolidis L, Oles M, Horak P, Heilig CE, Heining C, Hutter B, Gieldon L, Klink B, Lamping M, Rieke DT, Uhrig S, Jann H, Pape UF, Stenzinger A, Winkler EC, Wiedenmann B, Jaeger D, Brors B, Schroeck E, Keilholz U, Pavel ME, Glimm H, Froehling S (2019)


Publication Type: Conference contribution

Publication year: 2019

Journal

Publisher: AMER ASSOC CANCER RESEARCH

City/Town: PHILADELPHIA

Conference Proceedings Title: CANCER RESEARCH

Event location: Atlanta, GA US

DOI: 10.1158/1538-7445.AM2019-919

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Kreutzfeldt, S., Apostolidis, L., Oles, M., Horak, P., Heilig, C.E., Heining, C.,... Froehling, S. (2019). Clinical relevance of comprehensive genomic analysis in patients with advanced-stage neuroendocrine neoplasms: Results from the MASTER trial of the German Cancer Consortium. In CANCER RESEARCH. Atlanta, GA, US: PHILADELPHIA: AMER ASSOC CANCER RESEARCH.

MLA:

Kreutzfeldt, Simon, et al. "Clinical relevance of comprehensive genomic analysis in patients with advanced-stage neuroendocrine neoplasms: Results from the MASTER trial of the German Cancer Consortium." Proceedings of the AACR Annual Meeting on Bioinformatics, Convergence Science, and Systems Biology, Atlanta, GA PHILADELPHIA: AMER ASSOC CANCER RESEARCH, 2019.

BibTeX: Download